The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impact of cause of mismatch repair deficiency and other molecular markers on clinical outcomes with the use of durvalumab in advanced endometrial cancer in the phase 2 PHAEDRA trial (ANZGOG1601).
 
Daniel D. Buchanan
No Relationships to Disclose
 
Khalid Mahmood
No Relationships to Disclose
 
Peter Georgeson
No Relationships to Disclose
 
Romy Walker
No Relationships to Disclose
 
Kristy Robledo
No Relationships to Disclose
 
Michelle M. Cummins
No Relationships to Disclose
 
Amanda B. Spurdle
No Relationships to Disclose
 
Deborah S Smith
Employment - Mater Pathology
Stock and Other Ownership Interests - Sullivan Nicolaides Pathology
Research Funding - AstraZeneca
 
Eric Joo
No Relationships to Disclose
 
Mark Clendenning
No Relationships to Disclose
 
Julia Como
No Relationships to Disclose
 
Susan Preston
No Relationships to Disclose
 
Sonia Yip
No Relationships to Disclose
 
John Andrews
No Relationships to Disclose
 
Peey Sei Kok
Honoraria - AstraZeneca/MedImmune; Pfizer
Consulting or Advisory Role - MSD
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Pfizer
Other Relationship - AstraZeneca (Inst); Roche (Inst)
 
Yeh Chen Lee
Consulting or Advisory Role - GlaxoSmithKline
 
Martin R. Stockler
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Tilray (Inst)
 
Linda R. Mileshkin
Research Funding - BeiGene (Inst)
 
Yoland Catherine Antill
Honoraria - AstraZeneca; AstraZeneca/MedImmune; Eisai; Eisai
Consulting or Advisory Role - Eisai; GlaxoSmithKline; MSD Oncology
Speakers' Bureau - AstraZeneca
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Novartis